Fulcrum Therapeutics Inc (FULC) Stock: Uncovering 52-Week Market Trends

OPEN Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Fulcrum Therapeutics Inc’s current trading price is -52.34% away from its 52-week high, while its distance from the 52-week low is 107.96%. The stock’s price range over this period has fluctuated between $3.14 and $13.70. The company, operating within the financial sector, had a trading volume of approximately 0.59 million for the day, which was noticeably lower than the average daily share volume of 0.74 million over the last 3 months.

Fulcrum Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $13.70 on 03/06/24 and the lowest value was $3.14 on 10/27/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Fulcrum Therapeutics Inc (FULC) has experienced a quarterly decline of -22.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 405.84M and boasts a workforce of 76 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.32, with a change in price of -2.42. Similarly, Fulcrum Therapeutics Inc recorded 729,407 in trading volume during the last 100 days, posting a change of -27.04%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for FULC stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.04.

FULC Stock Stochastic Average

Today, Fulcrum Therapeutics Inc’s raw stochastic average for the past 50 days stands at 27.60%, indicating a decline from the raw stochastic average of the last 20 days, which was 30.91%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 20.44% and 17.33% respectively.

FULC Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -3.26%. However, over the past six months, we’ve seen a stronger performance of -13.28%. The price of FULC leaped by -21.98% over the last 30 days. And in the last five days, it has surged by 3.49%.

Most Popular